Lei Wen-Hua, Zhang Jia-Liang, Liao Yan-Biao, Wang Yan, Xu Fei, Zhang Yao-Yu, Xu Yanjiani, Zhou Jing, Huang Fang-Yang, Chen Mao
Department of Cardiology, West China Hospital, Sichuan University, No.37 Guoxue Street, Chengdu 610041, China.
Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, China.
J Geriatr Cardiol. 2025 Mar 28;22(3):351-360. doi: 10.26599/1671-5411.2025.03.008.
Hypertension is associated with an increased risk of calcific aortic valve stenosis (CAVS). However, the directionality of causation between blood pressure traits and aortic stenosis is unclear, as is the benefit of antihypertensive drugs for CAVS.
Using genome-wide association studies (GWAS) summary statistics, we performed bidirectional two-sample univariable mendelian randomization (UVMR) to assess the causal associations of systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure (PP) with CAVS. Multivariable mendelian randomization (MVMR) was conducted to evaluate the direct effect of hypertension on CAVS, adjusting for confounders. Drug target mendelian randomization (MR) and summary-level MR (SMR) were used to estimate the effects of 12 classes of antihypertensive drugs and their target genes on CAVS risk. Inverse variance weighting was the primary MR method, with sensitivity analyses to validate results.
UVMR showed SBP, DBP, and PP have causal effects on CAVS, with no significant reverse causality. MVMR confirmed the causality between hypertension and CAVS after adjusting for confounders. Drug-target MR analyses indicated that calcium channel blockers (CCBs), loop diuretics, and thiazide diuretics via SBP lowering exerted protective effects on CAVS risk. SMR analysis showed that the CCBs target gene and ARBs target gene were positively associated with CAVS risk, while diuretics target genes and were negatively associated with aortic stenosis risk.
Hypertension has a causal relationship with CAVS. Managing SBP in hypertensive patients with CCBs may prevent CAVS. ARBs might exert protective effects on CAVS independent of blood pressure reduction. The relationship between diuretics and CAVS is complex, with opposite effects through different mechanisms.
高血压与钙化性主动脉瓣狭窄(CAVS)风险增加相关。然而,血压特征与主动脉瓣狭窄之间因果关系的方向性尚不清楚,抗高血压药物对CAVS的益处也不明确。
利用全基因组关联研究(GWAS)汇总统计数据,我们进行了双向双样本单变量孟德尔随机化(UVMR),以评估收缩压(SBP)、舒张压(DBP)和脉压(PP)与CAVS之间的因果关联。进行多变量孟德尔随机化(MVMR)以评估高血压对CAVS的直接影响,并对混杂因素进行调整。药物靶点孟德尔随机化(MR)和汇总水平MR(SMR)用于估计12类抗高血压药物及其靶点基因对CAVS风险的影响。逆方差加权是主要的MR方法,并进行敏感性分析以验证结果。
UVMR显示SBP、DBP和PP对CAVS有因果效应,无明显的反向因果关系。MVMR在调整混杂因素后证实了高血压与CAVS之间的因果关系。药物靶点MR分析表明,钙通道阻滞剂(CCB)、袢利尿剂和噻嗪类利尿剂通过降低SBP对CAVS风险具有保护作用。SMR分析显示,CCB的靶点基因和血管紧张素Ⅱ受体阻滞剂(ARB)的靶点基因与CAVS风险呈正相关,而利尿剂的靶点基因和与主动脉瓣狭窄风险呈负相关。
高血压与CAVS存在因果关系。使用CCB控制高血压患者的SBP可能预防CAVS。ARB可能独立于血压降低对CAVS发挥保护作用。利尿剂与CAVS之间的关系复杂,通过不同机制产生相反作用。